Trial Profile
Pulse-Daylight-Photodynamic Therapy of Actinic Keratoses
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2016
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary) ; Clobetasol (Primary) ; Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Acronyms Pulse-Daylight-PDT of AK
- 20 Dec 2016 New trial record